Amid a viral pandemic with poorly understood transmissibility and pathogenicity in the pediatric patient, we report the first pediatric liver transplants utilizing allografts from SARS‐CoV‐2+ donors. Click to show full abstract
Amid a viral pandemic with poorly understood transmissibility and pathogenicity in the pediatric patient, we report the first pediatric liver transplants utilizing allografts from SARS‐CoV‐2+ donors.
               
Click one of the above tabs to view related content.